BACKGROUND: Population ancestry-based differences exist in genetic risk for many kidney diseases. Substantial debate remains regarding returning genetic test results to participants. African-Americans (AAs) and European-Americans (EAs) at risk for end-stage kidney disease were queried for views on the value and use of genetic testing in research. METHODS: A standardized survey regarding attitudes toward genetic testing was administered to 130 individuals (64 AA, 66 EA) with first-degree relatives on dialysis. Fisher's exact test was used to assess differences in participant attitudes between population groups. RESULTS: Mean (SD) age of surveyed AAs and EAs was 45.5 (12.8) and 50.5 (14.4) years, respectively (p = 0.04), with similar familial relationships (p = 0.22). AAs and EAs wished to know their test results if risk could be: (1) reduced by diet or exercise (100 and 98%, p = 0.99); (2) reduced by medical treatment (100 and 98%, p = 0.99), or (3) if no treatments were available (90 and 82%, p = 0.21). If informed they lacked a disease susceptibility variant, 87% of AAs and 88% of EAs would be extremely or pretty likely to inform family members (p = 0.84). If informed they had a disease susceptibility variant, 92% of AAs and 89% of EAs would be extremely or pretty likely to inform their family (p = 0.43). CONCLUSIONS: Attitudes toward obtaining and using genetic test results for disease in research contexts were similar in AAs and EAs at risk for end-stage kidney disease. A substantial majority would want information regardless of available treatments and would share the information with the family. These results have important implications for patient care, study design and the informed consent process.
BACKGROUND: Population ancestry-based differences exist in genetic risk for many kidney diseases. Substantial debate remains regarding returning genetic test results to participants. African-Americans (AAs) and European-Americans (EAs) at risk for end-stage kidney disease were queried for views on the value and use of genetic testing in research. METHODS: A standardized survey regarding attitudes toward genetic testing was administered to 130 individuals (64 AA, 66 EA) with first-degree relatives on dialysis. Fisher's exact test was used to assess differences in participant attitudes between population groups. RESULTS: Mean (SD) age of surveyed AAs and EAs was 45.5 (12.8) and 50.5 (14.4) years, respectively (p = 0.04), with similar familial relationships (p = 0.22). AAs and EAs wished to know their test results if risk could be: (1) reduced by diet or exercise (100 and 98%, p = 0.99); (2) reduced by medical treatment (100 and 98%, p = 0.99), or (3) if no treatments were available (90 and 82%, p = 0.21). If informed they lacked a disease susceptibility variant, 87% of AAs and 88% of EAs would be extremely or pretty likely to inform family members (p = 0.84). If informed they had a disease susceptibility variant, 92% of AAs and 89% of EAs would be extremely or pretty likely to inform their family (p = 0.43). CONCLUSIONS: Attitudes toward obtaining and using genetic test results for disease in research contexts were similar in AAs and EAs at risk for end-stage kidney disease. A substantial majority would want information regardless of available treatments and would share the information with the family. These results have important implications for patient care, study design and the informed consent process.
Authors: Giulio Genovese; David J Friedman; Michael D Ross; Laurence Lecordier; Pierrick Uzureau; Barry I Freedman; Donald W Bowden; Carl D Langefeld; Taras K Oleksyk; Andrea L Uscinski Knob; Andrea J Bernhardy; Pamela J Hicks; George W Nelson; Benoit Vanhollebeke; Cheryl A Winkler; Jeffrey B Kopp; Etienne Pays; Martin R Pollak Journal: Science Date: 2010-07-15 Impact factor: 47.728
Authors: Barry I Freedman; Jeffrey B Kopp; Carl D Langefeld; Giulio Genovese; David J Friedman; George W Nelson; Cheryl A Winkler; Donald W Bowden; Martin R Pollak Journal: J Am Soc Nephrol Date: 2010-08-05 Impact factor: 10.121
Authors: Samantha A Streicher; Saskia C Sanderson; Ethylin Wang Jabs; Michael Diefenbach; Meg Smirnoff; Inga Peter; Carol R Horowitz; Barbara Brenner; Lynne D Richardson Journal: J Community Genet Date: 2011-06-07
Authors: Charles R Jonassaint; Eunice R Santos; Crystal M Glover; Perry W Payne; Grace-Ann Fasaye; Nefertiti Oji-Njideka; Stanley Hooker; Wenndy Hernandez; Morris W Foster; Rick A Kittles; Charmaine D Royal Journal: Hum Genet Date: 2010-06-13 Impact factor: 4.132
Authors: Krzysztof Kiryluk; Yifu Li; Simone Sanna-Cherchi; Mersedeh Rohanizadegan; Hitoshi Suzuki; Frank Eitner; Holly J Snyder; Murim Choi; Ping Hou; Francesco Scolari; Claudia Izzi; Maddalena Gigante; Loreto Gesualdo; Silvana Savoldi; Antonio Amoroso; Daniele Cusi; Pasquale Zamboli; Bruce A Julian; Jan Novak; Robert J Wyatt; Krzysztof Mucha; Markus Perola; Kati Kristiansson; Alexander Viktorin; Patrik K Magnusson; Gudmar Thorleifsson; Unnur Thorsteinsdottir; Kari Stefansson; Anne Boland; Marie Metzger; Lise Thibaudin; Christoph Wanner; Kitty J Jager; Shin Goto; Dita Maixnerova; Hussein H Karnib; Judit Nagy; Ulf Panzer; Jingyuan Xie; Nan Chen; Vladimir Tesar; Ichiei Narita; Francois Berthoux; Jürgen Floege; Benedicte Stengel; Hong Zhang; Richard P Lifton; Ali G Gharavi Journal: PLoS Genet Date: 2012-06-21 Impact factor: 5.917
Authors: Sara L Laskey; Joseph Williams; Jacqui Pierre-Louis; MaryAnn O'Riordan; Anne Matthews; Nathaniel H Robin Journal: Genet Med Date: 2003 Jan-Feb Impact factor: 8.822
Authors: Alejandra M Mena-Gutierrez; Amber M Reeves-Daniel; Colleen L Jay; Barry I Freedman Journal: Transplantation Date: 2020-01 Impact factor: 4.939
Authors: Elisa J Gordon; Daniela Amόrtegui; Isaac Blancas; Catherine Wicklund; John Friedewald; Richard R Sharp Journal: Am J Kidney Dis Date: 2018-10-22 Impact factor: 8.860
Authors: Jessica N Cooke Bailey; Dana C Crawford; Aaron Goldenberg; Anne Slaven; Julie Pencak; Marleen Schachere; William S Bush; John R Sedor; John F O'Toole Journal: J Pers Med Date: 2018-06-26
Authors: Margaret Berrigan; Jasmine Austrie; Aaron Fleishman; Kenneth P Tercyak; Martin R Pollak; Martha Pavlakis; Vinayak Rohan; Prabhakar K Baliga; Liise K Kayler; Thomas H Feeley; James R Rodrigue Journal: Am J Transplant Date: 2020-08-29 Impact factor: 8.086
Authors: Barry I Freedman; Marva M Moxey-Mims; Amir A Alexander; Brad C Astor; Kelly A Birdwell; Donald W Bowden; Gordon Bowen; Jonathan Bromberg; Timothy E Craven; Darshana M Dadhania; Jasmin Divers; Mona D Doshi; Elling Eidbo; Alessia Fornoni; Michael D Gautreaux; Rasheed A Gbadegesin; Patrick O Gee; Giselle Guerra; Chi-Yuan Hsu; Ana S Iltis; Nichole Jefferson; Bruce A Julian; David K Klassen; Patrick P Koty; Carl D Langefeld; Krista L Lentine; Lijun Ma; Roslyn B Mannon; Madhav C Menon; Sumit Mohan; J Brian Moore; Barbara Murphy; Kenneth A Newell; Jonah Odim; Mariella Ortigosa-Goggins; Nicholette D Palmer; Meyeon Park; Afshin Parsa; Stephen O Pastan; Emilio D Poggio; Nishadi Rajapakse; Amber M Reeves-Daniel; Sylvia E Rosas; Laurie P Russell; Deirdre Sawinski; S Carrie Smith; Mitzie Spainhour; Robert J Stratta; Matthew R Weir; David M Reboussin; Paul L Kimmel; Daniel C Brennan Journal: Kidney Int Rep Date: 2019-12-13